Health ❯Pharmaceuticals ❯Weight Loss Drugs

GLP-1 Agonists

Semaglutide Eli Lilly vs. Novo Nordisk Prescription Trends Retatrutide Mechanism of Action Mounjaro Tirzepatide

U.S. Obesity Rates Decline for First Time in Over a Decade

A slight drop in obesity rates from 46% to 45.6% in 2023 is linked to the growing use of weight-loss drugs like Ozempic and Wegovy.

FDA Issues Warning on Overdoses from Compounded Semaglutide Injections

Youth Prescriptions for Weight Loss and Diabetes Drugs Surge Nearly 600%